PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α

por Thorpe, Lauren M., Spangle, Jennifer M., Ohlson, Carolynn E., Cheng, Hailing, Roberts, Thomas M., Cantley, Lewis C., Zhao, Jean J.
Publicado en Proc Natl Acad Sci U S A (2017)

PI3K/AKT signaling regulates H3K4 methylation in breast cancer

por Spangle, Jennifer M, Dreijerink, Koen M, Groner, Anna C, Cheng, Hailing, Ohlson, Carolynn E, Reyes, Jaime, Lin, Charles Y, Bradner, James, Zhao, Jean J, Roberts, Thomas M, Brown, Myles
Publicado en Cell Rep (2016)

A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 is highly responsive to mTOR inhibition

por Cheng, Hailing, Liu, Pixu, Zhang, Fan, Xu, Erbo, Symonds, Lynn, Ohlson, Carolynn E., Bronson, Roderick T., Maira, Sauveur-Michel, Tomaso, Emmanuelle Di, Li, Jane, Myers, Andrea P., C.Cantley, Lewis, Mills, Gordon B., Zhao, Jean J.
Publicado 2013

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

por Ding, Liya, Kim, Hye-Jung, Wang, Qiwei, Kearns, Michael, Jiang, Tao, Ohlson, Carolynn E., Li, Ben B., Xie, Shaozhen, Liu, Joyce F., Stover, Elizabeth H., Howitt, Brooke E., Bronson, Roderick T., Lazo, Suzan, Roberts, Thomas M., Freeman, Gordon J., Konstantinopoulos, Panagiotis A., Matulonis, Ursula A., Zhao, Jean J.
Publicado en Cell Rep (2018)